22-42130761-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000106.6(CYP2D6):​c.31G>A​(p.Val11Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0476 in 1,585,140 control chromosomes in the GnomAD database, including 4,366 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.039 ( 311 hom., cov: 31)
Exomes 𝑓: 0.049 ( 4055 hom. )

Consequence

CYP2D6
NM_000106.6 missense

Scores

18

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2O:1

Conservation

PhyloP100: -4.72

Publications

86 publications found
Variant links:
Genes affected
CYP2D6 (HGNC:2625): (cytochrome P450 family 2 subfamily D member 6) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]
NDUFA6-DT (HGNC:45273): (NDUFA6 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.001912564).
BP6
Variant 22-42130761-C-T is Benign according to our data. Variant chr22-42130761-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 676320.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0596 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP2D6NM_000106.6 linkc.31G>A p.Val11Met missense_variant Exon 1 of 9 ENST00000645361.2 NP_000097.3 P10635-1C1ID52Q5Y7H2
CYP2D6NM_001025161.3 linkc.31G>A p.Val11Met missense_variant Exon 1 of 8 NP_001020332.2 P10635-2Q5Y7H2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP2D6ENST00000645361.2 linkc.31G>A p.Val11Met missense_variant Exon 1 of 9 NM_000106.6 ENSP00000496150.1 P10635-1

Frequencies

GnomAD3 genomes
AF:
0.0388
AC:
5857
AN:
151124
Hom.:
312
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00927
Gnomad AMI
AF:
0.00440
Gnomad AMR
AF:
0.0223
Gnomad ASJ
AF:
0.0337
Gnomad EAS
AF:
0.00271
Gnomad SAS
AF:
0.00751
Gnomad FIN
AF:
0.0693
Gnomad MID
AF:
0.0633
Gnomad NFE
AF:
0.0611
Gnomad OTH
AF:
0.0366
GnomAD2 exomes
AF:
0.0380
AC:
7999
AN:
210718
AF XY:
0.0381
show subpopulations
Gnomad AFR exome
AF:
0.00856
Gnomad AMR exome
AF:
0.0226
Gnomad ASJ exome
AF:
0.0359
Gnomad EAS exome
AF:
0.00220
Gnomad FIN exome
AF:
0.0666
Gnomad NFE exome
AF:
0.0563
Gnomad OTH exome
AF:
0.0446
GnomAD4 exome
AF:
0.0485
AC:
69567
AN:
1433902
Hom.:
4055
Cov.:
33
AF XY:
0.0481
AC XY:
34204
AN XY:
710904
show subpopulations
African (AFR)
AF:
0.00810
AC:
265
AN:
32734
American (AMR)
AF:
0.0237
AC:
982
AN:
41356
Ashkenazi Jewish (ASJ)
AF:
0.0360
AC:
925
AN:
25670
East Asian (EAS)
AF:
0.00131
AC:
51
AN:
38816
South Asian (SAS)
AF:
0.00802
AC:
662
AN:
82570
European-Finnish (FIN)
AF:
0.0654
AC:
3363
AN:
51452
Middle Eastern (MID)
AF:
0.0317
AC:
175
AN:
5516
European-Non Finnish (NFE)
AF:
0.0553
AC:
60604
AN:
1096580
Other (OTH)
AF:
0.0429
AC:
2540
AN:
59208
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.432
Heterozygous variant carriers
0
3168
6336
9505
12673
15841
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2044
4088
6132
8176
10220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0387
AC:
5857
AN:
151238
Hom.:
311
Cov.:
31
AF XY:
0.0380
AC XY:
2812
AN XY:
73922
show subpopulations
African (AFR)
AF:
0.00924
AC:
379
AN:
41012
American (AMR)
AF:
0.0222
AC:
338
AN:
15210
Ashkenazi Jewish (ASJ)
AF:
0.0337
AC:
117
AN:
3470
East Asian (EAS)
AF:
0.00271
AC:
14
AN:
5160
South Asian (SAS)
AF:
0.00773
AC:
37
AN:
4788
European-Finnish (FIN)
AF:
0.0693
AC:
733
AN:
10582
Middle Eastern (MID)
AF:
0.0612
AC:
18
AN:
294
European-Non Finnish (NFE)
AF:
0.0612
AC:
4141
AN:
67716
Other (OTH)
AF:
0.0363
AC:
76
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
215
430
645
860
1075
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0532
Hom.:
204
Bravo
AF:
0.0343
TwinsUK
AF:
0.0523
AC:
194
ALSPAC
AF:
0.0480
AC:
185
ESP6500AA
AF:
0.00820
AC:
36
ESP6500EA
AF:
0.0581
AC:
499
ExAC
AF:
0.0345
AC:
4138
Asia WGS
AF:
0.00783
AC:
27
AN:
3464

ClinVar

Significance: Likely benign
Submissions summary: Benign:2Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Apr 12, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Tramadol response Other:1
Apr 28, 2018
Bruce Budowle Laboratory, University of North Texas Health Science Center
Significance:drug response
Review Status:no assertion criteria provided
Collection Method:research

- T:M1 = postmortem ratio or tramadol to O-desmethyltramadol; t-MP = model-based clustered metabolizer phenotype inferred from T:M1

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.66
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
0.30
DANN
Benign
0.73
DEOGEN2
Benign
0.016
T;T;T;.
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.012
N
LIST_S2
Benign
0.73
.;.;T;T
MetaRNN
Benign
0.0019
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.34
N;N;N;N
PhyloP100
-4.7
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-1.4
.;.;N;N
REVEL
Benign
0.036
Sift
Benign
0.11
.;.;T;T
Sift4G
Benign
0.14
.;.;T;T
Vest4
0.015, 0.052
MPC
0.11
ClinPred
0.0050
T
GERP RS
-3.0
PromoterAI
0.051
Neutral
Varity_R
0.012
gMVP
0.35
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs769258; hg19: chr22-42526763; COSMIC: COSV62244550; COSMIC: COSV62244550; API